These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 14633140

  • 1. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
    Fujihara CK, Antunes GR, Mattar AL, Andreoli N, Malheiros DM, Noronha IL, Zatz R.
    Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
    [Abstract] [Full Text] [Related]

  • 2. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL, Cheng HF, Shappell S, Harris RC.
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension.
    Cheng HF, Wang CJ, Moeckel GW, Zhang MZ, McKanna JA, Harris RC.
    Kidney Int; 2002 Sep; 62(3):929-39. PubMed ID: 12164875
    [Abstract] [Full Text] [Related]

  • 4. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G, Zatz R.
    Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
    [Abstract] [Full Text] [Related]

  • 5. Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats.
    Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B.
    J Hypertens; 2004 Jan; 22(1):191-8. PubMed ID: 15106811
    [Abstract] [Full Text] [Related]

  • 6. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
    Hermann M, Shaw S, Kiss E, Camici G, Bühler N, Chenevard R, Lüscher TF, Gröne HJ, Ruschitzka F.
    Hypertension; 2005 Feb; 45(2):193-7. PubMed ID: 15630049
    [Abstract] [Full Text] [Related]

  • 7. Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP-kinase-dependent process.
    Dunlop ME, Muggli EE.
    Kidney Int; 2002 May; 61(5):1729-38. PubMed ID: 11967022
    [Abstract] [Full Text] [Related]

  • 8. Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats.
    Oztürk H, Ozdemir E, Otcu S, Büyükbayram H, Ihsan Dokucu A.
    Urol Res; 2002 Sep; 30(4):223-6. PubMed ID: 12202939
    [Abstract] [Full Text] [Related]

  • 9. Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression.
    Waldner C, Heise G, Meyer-Kirchrath J, Schrör K, Grabensee B, Heering P.
    Nephron Exp Nephrol; 2003 Sep; 93(2):e72. PubMed ID: 12629275
    [Abstract] [Full Text] [Related]

  • 10. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development.
    Kömhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD.
    Kidney Int; 2000 Feb; 57(2):414-22. PubMed ID: 10652018
    [Abstract] [Full Text] [Related]

  • 11. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S, Johns EJ.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [Abstract] [Full Text] [Related]

  • 12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
    López-Parra M, Clària J, Planagumà A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jiménez W, Altuna R, Arroyo V, Rivera F, Rodés J.
    Br J Pharmacol; 2002 Feb 01; 135(4):891-900. PubMed ID: 11861316
    [Abstract] [Full Text] [Related]

  • 14. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

  • 15. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence.
    Muscará MN, Vergnolle N, Lovren F, Triggle CR, Elliott SN, Asfaha S, Wallace JL.
    Br J Pharmacol; 2000 Apr 15; 129(7):1423-30. PubMed ID: 10742298
    [Abstract] [Full Text] [Related]

  • 16. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
    Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM, Zatz R.
    Am J Physiol Renal Physiol; 2007 Jan 15; 292(1):F92-9. PubMed ID: 16896182
    [Abstract] [Full Text] [Related]

  • 17. [Renal protective effects of specific cyclooxygenase-2 inhibitor in rats with subtotal renal ablation].
    Kong WX, Ma J, Gu Y, Yang HC, Zuo YQ, Lin SY.
    Zhonghua Nei Ke Za Zhi; 2003 Mar 15; 42(3):186-90. PubMed ID: 12816702
    [Abstract] [Full Text] [Related]

  • 18. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C, Heise G, Mühlfeld A, Bach D, Schrör K, Gerhardz CD, Grabensee B, Heering P.
    Kidney Int; 1999 Nov 15; 56(5):1770-8. PubMed ID: 10571785
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.
    Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J.
    Gastroenterology; 1999 May 15; 116(5):1167-75. PubMed ID: 10220509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.